These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20153642)

  • 1. Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe)--against colon cancer.
    Desai D; Madhunapantula SV; Gowdahalli K; Sharma A; Chandagaludoreswamy R; El-Bayoumy K; Robertson GP; Amin S
    Bioorg Med Chem Lett; 2010 Mar; 20(6):2038-43. PubMed ID: 20153642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBISe, a novel selenium-containing drug for the treatment of malignant melanoma.
    Madhunapantula SV; Desai D; Sharma A; Huh SJ; Amin S; Robertson GP
    Mol Cancer Ther; 2008 May; 7(5):1297-308. PubMed ID: 18483317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selenium analog of the chemopreventive compound S,S'-(1,4-phenylenebis[1,2-ethanediyl])bisisothiourea is a remarkable inducer of apoptosis and inhibitor of cell growth in human non-small cell lung cancer.
    Das A; Bortner J; Desai D; Amin S; El-Bayoumy K
    Chem Biol Interact; 2009 Jul; 180(2):158-64. PubMed ID: 19497413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facile one-pot synthesis of thio and selenourea derivatives: a new class of potent urease inhibitors.
    Sivapriya K; Suguna P; Banerjee A; Saravanan V; Rao DN; Chandrasekaran S
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6387-91. PubMed ID: 17889535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma prevention using topical PBISe.
    Chung CY; Madhunapantula SV; Desai D; Amin S; Robertson GP
    Cancer Prev Res (Phila); 2011 Jun; 4(6):935-48. PubMed ID: 21367959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell lines.
    Alcolea V; Plano D; Karelia DN; Palop JA; Amin S; Sanmartín C; Sharma AK
    Eur J Med Chem; 2016 May; 113():134-44. PubMed ID: 26922233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats.
    Janakiram NB; Mohammed A; Ravillah D; Choi CI; Zhang Y; Desai D; Amin S; Rao CV
    Oncol Rep; 2013 Aug; 30(2):952-60. PubMed ID: 23708609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
    Rao CV; Kawamori T; Hamid R; Reddy BS
    Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer.
    Tagaram HR; Desai D; Li G; Liu D; Rountree CB; Gowda K; Berg A; Amin S; Staveley-O'Carroll KF; Kimchi ET
    Pharmaceuticals (Basel); 2016 Mar; 9(2):. PubMed ID: 27023566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
    Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
    Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected C-Se cross-coupling reaction: copper oxide catalyzed synthesis of symmetrical diaryl selenides via cascade reaction of selenourea with aryl halides/boronic acids.
    Reddy VP; Kumar AV; Rao KR
    J Org Chem; 2010 Dec; 75(24):8720-3. PubMed ID: 21090802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and orally bioavailable inducible nitric oxide synthase inhibitors: synthesis and evaluation of optically active 4,5-dialkyl-2-iminoselenazolidine derivatives.
    Ueda S; Terauchi H; Suzuki K; Yano A; Matsumoto M; Kubo T; Minato H; Arai Y; Tsuji J; Watanabe N
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1361-6. PubMed ID: 15713387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactions of Nitroxides, Part 17. Synthesis, Fungistatic and Bacteriostatic Activity of Novel Five- and Six-Membered Nitroxyl Selenoureas and Selenocarbamates.
    Zakrzewski J; Huras B; Kiełczewska A; Krawczyk M; Hupko J; Jaszczuk K
    Molecules; 2019 Jul; 24(13):. PubMed ID: 31277425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of urea and thiourea kynurenamine derivatives: synthesis, molecular modeling, and biological evaluation as nitric oxide synthase inhibitors.
    Chayah M; Carrión MD; Gallo MA; Jiménez R; Duarte J; Camacho ME
    ChemMedChem; 2015 May; 10(5):874-82. PubMed ID: 25801086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells.
    Narayanan BA; Narayanan NK; Desai D; Pittman B; Reddy BS
    Carcinogenesis; 2004 Dec; 25(12):2443-9. PubMed ID: 15297372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenosteroids - promising hybrid compounds with pleiotropic biological activity: synthesis and biological aspects.
    Jastrzebska I; Grzes PA; Niemirowicz-Laskowska K; Car H
    J Steroid Biochem Mol Biol; 2021 Oct; 213():105975. PubMed ID: 34418527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of organoselenium compounds for potential chemopreventive properties in colon cancer.
    Reddy BS; Wynn TT; el-Bayoumy K; Upadhyaya P; Fiala E; Rao CV
    Anticancer Res; 1996; 16(3A):1123-7. PubMed ID: 8702223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiorgan sensitivity to anticarcinogenesis by the organoselenium 1,4-phenylenebis(methylene)selenocyanate.
    el-Bayoumy K; Rao CV; Reddy BS
    Nutr Cancer; 2001; 40(1):18-27. PubMed ID: 11799918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antioxidant activity of O-alkyl selenocarbamates, selenoureas and selenohydantoins.
    Merino-Montiel P; Maza S; Martos S; López Ó; Maya I; Fernández-Bolaños JG
    Eur J Pharm Sci; 2013 Feb; 48(3):582-92. PubMed ID: 23287366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.